Sanfetrinem sodium  (Synonyms: GV104326 sodium)

Sanfetrinem (GV104326) sodium is a beta-lactamase-stable antibiotic. Sanfetrinem sodium has broad-spectrum activity against gram-positive and gram-negative bacteria^[1].

Sanfetrinem (4 μg/mL) sodium inhibits 99.5% of the strains, including B. fragilisgroup, B. fragilis,  B. thetaiotaomicron, B. uniformis^[1].
Sanfetrinem sodium shows potent activity against Staphylococcus aureus with a MIC₉₀ of 0.06 μg/mL^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

303.29

C₁₄H₁₈NNaO₅

141611-76-9

C[C@H]([C@]1([H])[C@]2([H])N(C(C(O[Na])=O)=C3[C@]2([H])CCC[C@@H]3OC)C1=O)O

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Betriu C, et al. Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents. Antimicrob Agents Chemother. 1999 Sep;43(9):2320-2.  [Content Brief]

  [2]. Tamura S, et al. In vivo antibacterial activities of sanfetrinem cilexetil, a new oral tricyclic antibiotic. Antimicrob Agents Chemother. 1998 Jul;42(7):1858-61.  [Content Brief]